A Bayesian approach for estimating antiviral efficacy in HIV dynamic models
From MaRDI portal
Publication:3426396
DOI10.1080/02664760500250552zbMath1106.62121OpenAlexW2076296035MaRDI QIDQ3426396
Publication date: 8 March 2007
Published in: Journal of Applied Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/02664760500250552
Applications of statistics to biology and medical sciences; meta analysis (62P10) Bayesian inference (62F15) Numerical analysis or methods applied to Markov chains (65C40)
Related Items (26)
Hierarchical Bayesian inference for HIV dynamic differential equation models incorporating multiple treatment factors ⋮ Identifiability analysis of linear ordinary differential equation systems with a single trajectory ⋮ Numerical Discretization-Based Estimation Methods for Ordinary Differential Equation Models via Penalized Spline Smoothing with Applications in Biomedical Research ⋮ Bayesian estimation of time-varying parameters in ordinary differential equation models with noisy time-varying covariates ⋮ Bayesian inference of mixed-effects ordinary differential equations models using heavy-tailed distributions ⋮ Bayesian penalized B-spline estimation approach for epidemic models ⋮ Practical identifiability of HIV dynamics models ⋮ Parameter estimation based synchronization for an epidemic model with application to tuberculosis in Cameroon ⋮ A mathematical model for the dynamics and MCMC analysis of tomato bacterial wilt disease ⋮ A tracking approach to parameter estimation in linear ordinary differential equations ⋮ Parameter and state estimation in a Neisseria meningitidis model: A study case of Niger ⋮ A Bayesian approach to estimate parameters of ordinary differential equation ⋮ A Bayesian approach in differential equation dynamic models incorporating clinical factors and covariates ⋮ Parameter identifiability and estimation of HIV/AIDS dynamic models ⋮ A model incorporating combined RTIs and PIs therapy during early HIV-1 infection ⋮ A dynamic Bayesian nonlinear mixed-effects model of HIV response incorporating medication adherence, drug resistance and covariates ⋮ Modeling the dynamics of biomarkers during primary HIV infection taking into account the uncertainty of infection date ⋮ Estimation of constant and time-varying dynamic parameters of HIV infection in a nonlinear differential equation model ⋮ Modeling long-term longitudinal HIV dynamics with application to an AIDS clinical study ⋮ Bayesian inference of a directional brain network model for intracranial EEG data ⋮ Comments on: Dynamic relations for sparsely sampled Gaussian processes ⋮ Smooth functional tempering for nonlinear differential equation models ⋮ Long-term HIV dynamic models incorporating drug adherence and resistance to treatment for prediction of virological responses ⋮ Parameter Estimation and Variable Selection for Big Systems of Linear Ordinary Differential Equations: A Matrix-Based Approach ⋮ Semiparametric mixed-effects ordinary differential equation models with heavy-tailed distributions ⋮ Parameter Estimation of Partial Differential Equation Models
Uses Software
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity
- Dynamics of HIV infection of CD4\(^ +\) T cells
- Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics
- Sampling-Based Approaches to Calculating Marginal Densities
- Stochastic Relaxation, Gibbs Distributions, and the Bayesian Restoration of Images
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions
- Population HIV‐1 Dynamics In Vivo: Applicable Models and Inferential Tools for Virological Data from AIDS Clinical Trials
- Bayesian Analysis of Linear and Non-Linear Population Models by Using the Gibbs Sampler
This page was built for publication: A Bayesian approach for estimating antiviral efficacy in HIV dynamic models
